Roivant Sciences Ltd. (ROIV) Balance Sheet
As of 2026-06-30 (10-Q), Roivant Sciences Ltd. (ROIV) reported total assets of $5.3B, total liabilities of $384.6M and shareholders' equity of $4.2B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $1.2B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ROIVRoivant Sciences Ltd.Follow ROIV — free
—
Price chart with a free account
- Market cap
- 26.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2022 Mar 22 | FY2023 Mar 23 | FY2024 Mar 24 | FY2025 Mar 25 | FY2026 Mar 26 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.06 | 1.68 | 6.49 | 2.72 | 1.42 | 1.25 | |
| Short-term investments | — | — | 0.00 | 2.17 | 2.87 | 2.59 | |
| Receivables | 0.00 | 0.03 | 0.00 | — | — | — | |
| Inventory | 0.00 | 0.00 | 0.04 | — | — | — | |
| Current assets | 2.15 | 1.80 | 6.73 | 5.00 | 5.17 | 4.74 | |
| Total assets | 2.59 | 2.39 | 7.22 | 5.44 | 5.71 | 5.31 | |
| Current liabilities | 0.18 | 0.27 | 0.27 | 0.15 | 0.28 | 0.28 | |
| Long-term debt | 0.21 | 0.38 | 0.43 | — | — | — | |
| Short-term debt | 0.00 | 0.04 | 0.01 | — | — | — | |
| Total liabilities | 0.52 | 0.78 | 0.77 | 0.25 | 0.42 | 0.38 | |
| Shareholders' equity | 1.66 | 1.16 | 5.97 | 4.69 | 4.53 | 4.23 |
USD billions · SEC XBRL
Roivant Sciences Ltd. — questions
- How much cash does Roivant Sciences Ltd. have?
- $1.2B in cash and cash equivalents as of 2026-06-30.
- What are Roivant Sciences Ltd.'s total assets?
- $5.3B as of 2026-06-30.
- What is Roivant Sciences Ltd.'s shareholders' equity?
- $4.2B as of 2026-06-30.
Every figure on this page comes from Roivant Sciences Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.